Skip to content
★ Sign in to follow
Total declarations
16
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 20 Aug 2010 for Lineage Cell Therapeutics, Inc., €963.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

No signal scores available.

Gary K. Duberstein: trading record in brief

This profile gathers the share dealings of Gary K. Duberstein in Lineage Cell Therapeutics, Inc. We count 16 filings; the first trade dates from 16 January 2007 and the latest from 18 August 2010.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

On 20 August 2010 came the latest disclosure, a share grant for €963 in Lineage Cell Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 17 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Gary K. Duberstein

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total

16 of 16 declarations